Reuters logo
2 months ago
BRIEF-Aclaris Therapeutics starts clinical trials of A-101 for treatment of common warts
June 29, 2017 / 12:35 PM / 2 months ago

BRIEF-Aclaris Therapeutics starts clinical trials of A-101 for treatment of common warts

June 29 (Reuters) - Aclaris Therapeutics Inc

* Aclaris Therapeutics initiates phase 2b clinical trials of A-101 for topical treatment of common warts

* ‍initiation of two phase 2 clinical trials to evaluate A-101 45 pct topical solution,investigational drug for treatment of common warts​

* ‍phase 2B studies will evaluate safety, tolerability and dose-frequency of A-101 45 pct compared with its vehicle (placebo)​

* ABT 240 patients to be randomized in two double-blinded trials which are being conducted at 30 investigational centers within U.S. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below